In this work, we employed whole exome sequencing (WES) to identify novel susceptibility genes for hereditary melanoma in patients with MPM, who were negative for germline mutations in the genes CDKN2A, CDK4, and MITF (p.E318K). The gene discussed is CDKN2A; the disease is melanoma.